Biotest Aktiengesellschaft (ETR:BIO – Get Free Report)’s stock price traded down 1.4% on Tuesday . The company traded as low as €40.60 ($41.86) and last traded at €40.80 ($42.06). 121 shares were traded during trading, a decline of 94% from the average session volume of 1,927 shares. The stock had previously closed at €41.40 ($42.68).
Biotest Aktiengesellschaft Trading Down 1.4 %
The company’s fifty day simple moving average is €41.47 and its 200-day simple moving average is €41.63. The firm has a market capitalization of $807.43 million, a PE ratio of 9.83 and a beta of 0.24. The company has a debt-to-equity ratio of 116.50, a current ratio of 2.45 and a quick ratio of 1.66.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
See Also
- Five stocks we like better than Biotest Aktiengesellschaft
- Comparing and Trading High PE Ratio Stocks
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Overbought Stocks Explained: Should You Trade Them?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
